Funding Received
$11.4 Million in 2 Rounds from 4 Investors
Most Recent Funding
$6 Million Series A on June 21, 2013
Founded:
2010
Headquarters:
Providence, RI
Description:
Mnemosyne Pharmaceuticals is developing an innovative drug discovery platform addressing the medical needs in the mental health market.
Categories:
Biotechnology
Website:
http://mnemosynepharma.com

Detailed Description

Update

Mnemosyne Pharmaceuticals, Inc. is developing an innovative drug discovery platform that will address medical needs in several segments of the mental health market.

Mnemosyne was founded in 2010 with seed funding from Slater Technology Fund and private investors. Recently, Mnemosyne closed on a Series A round totaling $5.4M. Mnemosyne is using these funds to develop a new class of small molecule drugs that modulate the activity of different subtypes of the NMDA receptor.

Current Team (2)

Update

Funding Rounds (2) - $11.4M

Update

Board Members and Advisors (1)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    One Davol Square

    Suite 200

    Providence, RI 02903

    USA

Images (1)

Update
  • 0ad842426b41515d40c6b3a9d5163aad